Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$5.86 – $47.00
8% from low
No one on the platform currently holds FLGC.
No tracked institution reports a position in FLGC as of their last filing.
| Execution date | Ratio |
|---|---|
| 2025-08-04 | 1-for-39reverse |
| 2023-06-09 | 1-for-20reverse |
No one on the platform has traded FLGC yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Beat consensus in 1 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2025-11-05 | $-2.13 | $-4.93 | -131.5% |
| 2025-08-01 | $-2.34 | $-4.30 | -83.8% |
| 2025-05-13 | $-0.39 | $-1.56 | -300.0% |
| 2025-03-24 | $-6.63 | $-16.41 | -147.5% |
| 2024-11-13 | $-3.43 | $-0.83 | +75.8% |
| 2024-08-12 | $-1.72 | $-8.59 | -398.3% |
| 2024-05-14 | $-8.49 | $-10.94 | -28.9% |
| 2024-03-29 | $-0.07 | $-0.17 | -142.9% |
| $44M |
| — |
| ENSCEnsysce Biosciences, Inc. | $0.35 | -12.59% | $5M | — |
| KALAKALA BIO, Inc. | $0.92 | +4.52% | $18M | — |
Source: Financial Modeling Prep · peers by sector/industry